Related references
Note: Only part of the references are listed.The role of IL-6 in host defence against infections: immunobiology and clinical implications
Stefan Rose-John et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Genetic polymorphisms of interleukin 6 and interleukin 10 in Egyptian patients with systemic lupus eythematosus
R. M. Talaat et al.
LUPUS (2016)
An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation
M. Florencia Iulita et al.
ALZHEIMERS & DEMENTIA (2016)
Balancing the immune response in the brain: IL-10 and its regulation
Diogo Lobo-Silva et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Children with Down syndrome: Clinical course and mortality-associated factors in a French medical paediatric intensive care unit
Christelle Joffre et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2016)
Differential Expression of Inflammation-Related Genes in Children with Down Syndrome
Claudia Regina Santos Silva et al.
MEDIATORS OF INFLAMMATION (2016)
Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms
Fan Su et al.
NEUROSCIENCE BULLETIN (2016)
Coenzyme Q10 and pro-inflammatory markers in children with Down syndrome: clinical and biochemical aspects
Moushira E. Zaki et al.
Jornal de Pediatria (2016)
Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients
Jung-Woo Chae et al.
PLOS ONE (2016)
Association of interleukin-6 gene polymorphism (rs1800796) with severity and functional status of osteoarthritis in elderly individuals
Marcos T. P. Fernandes et al.
CYTOKINE (2015)
IL-10 Alters Immunoproteostasis in APP Mice, Increasing Plaque Burden and Worsening Cognitive Behavior
Paramita Chakrabarty et al.
NEURON (2015)
Decrease of interleukin (IL)17A gene expression in leucocytes and in the amount of IL-17A protein in CD4+T cells in children with Down Syndrome
Anna Jakubiuk-Tomaszuk et al.
PHARMACOLOGICAL REPORTS (2015)
Association between polymorphisms in the promoter region of interleukin-10 and susceptibility to inflammatory bowel disease
Hongchao Lv et al.
MOLECULAR BIOLOGY REPORTS (2014)
Interleukin-10 Promoter 1082/-819/-592 Polymorphisms are Associated with Asthma Susceptibility in Asians and Atopic Asthma: A Meta-Analysis
Xue-yan Zheng et al.
LUNG (2014)
Increased production of interleukin-10 in children with Down syndrome upon ex vivo stimulation with Streptococcus pneumoniae
Chantal J. M. Broers et al.
PEDIATRIC RESEARCH (2014)
Association between IL-10 Gene Polymorphisms and Susceptibility of Tuberculosis: Evidence Based on a Meta-Analysis
Bin Liang et al.
PLOS ONE (2014)
Altered Expression of Immune-Related Genes in Children with Down Syndrome
Bruna Lancia Zampieri et al.
PLOS ONE (2014)
Hospitalization of children with Down syndrome
Ariel Tenenbaum et al.
FRONTIERS IN PUBLIC HEALTH (2014)
Interleukin-10-1082A/G polymorphism and inflammatory bowel disease susceptibility: A meta-analysis based on 17,585 subjects
Hang Zhu et al.
CYTOKINE (2013)
Associations between interleukin-10 polymorphisms and susceptibility to systemic lupus erythematosus: A meta-analysis
Gwan Gyu Song et al.
HUMAN IMMUNOLOGY (2013)
Is the IL-10 Promoter Polymorphism at Position-592 Associated with Immune System-Related Diseases?
Mojgan Noroozi Karimabad et al.
INFLAMMATION (2013)
Association of the interleukin-10 gene polymorphism (-1082A/G) with systemic lupus erythematosus: a meta-analysis
M. Zhou et al.
LUPUS (2013)
IL-10 Treatment Is Associated with Prohibitin Expression in the Crohn's Disease Intestinal Fibrosis Mouse Model
C. Yuan et al.
MEDIATORS OF INFLAMMATION (2013)
IL-10 Gene Polymorphisms and Susceptibility to Systemic Lupus Erythematosus: A Meta-Analysis
Ping Liu et al.
PLOS ONE (2013)
Cytokine and Chemokine Alterations in Down Syndrome
Robin Roberson et al.
AMERICAN JOURNAL OF PERINATOLOGY (2012)
T-helper-related cytokines in gingival crevicular fluid from adolescents with Down syndrome
Georgios Tsilingaridis et al.
CLINICAL ORAL INVESTIGATIONS (2012)
Cytokine receptor activation at the cell surface
Sophie E. Broughton et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2012)
Interleukin-10 promoter polymorphisms and asthma risk: A meta-analysis
Wei Nie et al.
CYTOKINE (2012)
Interleukin (IL)-10 Gene Polymorphisms Are Associated with Type 2 Diabetes With and Without Nephropathy: A Study of Patients from the Southeast Region of Iran
Mohammad Kazemi Arababadi et al.
INFLAMMATION (2012)
Increased Pro-inflammatory Cytokine Production in Down syndrome Children Upon Stimulation with Live Influenza A Virus
Chantal J. M. Broers et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Role of Interleukin 10 Transcriptional Regulation in Inflammation and Autoimmune Disease
Shankar Subramanian Iyer et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2012)
Altered serum pro-inflammatory cytokines in children with Down's syndrome
Mahmoud Nateghi Rostami et al.
EUROPEAN CYTOKINE NETWORK (2012)
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Juergen Scheller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Infections and immunodeficiency in Down syndrome
G. Ram et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
The-1082A/G polymorphism in the Interleukin-10 gene and the risk of rheumatoid arthritis: A meta-analysis
Jie Zhang et al.
CYTOKINE (2011)
CC Chemokine Receptor 2 Deficiency Aggravates Cognitive Impairments and Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
Gaelle Naert et al.
JOURNAL OF NEUROSCIENCE (2011)
Association of polymorphisms in the human IL-10 and IL-18 genes with rheumatoid arthritis
Binwu Ying et al.
MOLECULAR BIOLOGY REPORTS (2011)
Hippocampal expression of murine TNFα results in attenuation of amyloid deposition in vivo
Paramita Chakrabarty et al.
MOLECULAR NEURODEGENERATION (2011)
Interleukin-6-174G/C polymorphism and the risk of Alzheimer's disease in Caucasians: A meta-analysis
Xue-Mei Han et al.
NEUROSCIENCE LETTERS (2011)
Inflammatory and Immunological parameters in adults with Down syndrome
Maria BF Trotta et al.
Immunity & Ageing (2011)
Assessing Activation States in Microglia
Carol A. Colton et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome
S. Cetiner et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2010)
Interleukin-10 gene promoter polymorphism in Polish rheumatoid arthritis patients
A. Paradowska-Gorycka et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2010)
IFN-γ Promotes Complement Expression and Attenuates Amyloid Plaque Deposition in Amyloid β Precursor Protein Transgenic Mice
Paramita Chakrabarty et al.
JOURNAL OF IMMUNOLOGY (2010)
Interleukin 10 and Tumor Necrosis Factor-α Genotypes in Rheumatoid Arthritis - Association with Clinical Response to Glucocorticoids
Banesa de Paz et al.
JOURNAL OF RHEUMATOLOGY (2010)
Unique clinical and biological features of leukemia in Down syndrome children
Ana C. Xavier et al.
EXPERT REVIEW OF HEMATOLOGY (2010)
Powerful beneficial effects of macrophage colony-stimulating factor on -amyloid deposition and cognitive impairment in Alzheimers disease
Vincent Boissonneault et al.
BRAIN (2009)
Interleukin-6 promoter polymorphisms (-174 G/C) in Malaysian patients with systemic lupus erythematosus
K. H. Chua et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2009)
Cytokine Gene Polymorphisms across Tuberculosis Clinical Spectrum in Pakistani Patients
Ambreen Ansari et al.
PLOS ONE (2009)
T Lymphocyte Maturation Is Impaired in Healthy Young Individuals Carrying Trisomy 21 (Down Syndrome)
Laura Guazzarotti et al.
AJIDD-AMERICAN JOURNAL ON INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (2009)
Homeostatic cytokines and expansion of regulatory T cells accompany thymic impairment in children with Down syndrome
Erika Roat et al.
REJUVENATION RESEARCH (2008)
Association of IL-10 polymorphisms with prostate cancer risk and grade of disease
Jessica M. Faupel-Badger et al.
CANCER CAUSES & CONTROL (2008)
Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology
Solomon S. Shaftel et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Microglial activation is required for Aβ clearance after intracranial injection of lipopolysaccharide in APP transgenic mice
Donna L. Herber et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2007)
Polymorphisms in the interleukin 6 and transforming growth factor β1 gene and risk of dementia -: The Rotterdam Study
Marieke van Oijen et al.
NEUROSCIENCE LETTERS (2006)
Genetic variation in IL6 gene and type 2 diabetes:: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis
Lu Qi et al.
HUMAN MOLECULAR GENETICS (2006)
Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology
JJM Hoozemans et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2006)
Selected neurotrophins, neuropeptides, and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome
PG Nelson et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2006)
The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer
CM Shih et al.
LUNG CANCER (2005)
Glia and their cytokines in progression of neurodegeneration
RE Mrak et al.
NEUROBIOLOGY OF AGING (2005)
IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma
W Cozen et al.
BLOOD (2004)
Neuroinflammatory perspectives on the two faces of Alzheimer's disease
P Eikelenboom et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
Genetic predisposition of the interleukin-6 response to inflammation: Implications for a variety of major diseases?
M Bennermo et al.
CLINICAL CHEMISTRY (2004)
Prognostic value of plasma interleukin-6 concentrations and the -174 G>C and -572 G>C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis
M Bennermo et al.
ATHEROSCLEROSIS (2004)
Association of an allelic variant of interleukin-6 with subclinical carotid atherosclerosis in an Australian community population
CML Chapman et al.
EUROPEAN HEART JOURNAL (2003)
The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians
B Vozarova et al.
HUMAN GENETICS (2003)
Interfleukin-10 promoter polymorphism in sporadic Alzheimer's disease
D Lio et al.
GENES AND IMMUNITY (2003)
The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease
A Flex et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2002)
Innate immunity: The missing link in neuroprotection and neurodegeneration?
MD Nguyen et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis
B Schluter et al.
CRITICAL CARE MEDICINE (2002)
Regulation of chemokine expression by antiinflammatory cytokines
TA Hamilton et al.
IMMUNOLOGIC RESEARCH (2002)
Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: Granulomatous pathology is shaped by the pattern of L-arginine metabolism
M Hesse et al.
JOURNAL OF IMMUNOLOGY (2001)
Inflammatory factors are elevated in brain microvessels in Alzheimer's disease
P Grammas et al.
NEUROBIOLOGY OF AGING (2001)
Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation
CF Terry et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)